Boehringer takes over CA facility of client Amgen

Contract manufacturer Boehringer Ingelheim has formally taken ownership of the Fremont, CA, biopharma development and manufacturing facility of long-time client Amgen. The 200,000 square feet of lab, manufacturing and process development space represents a fully integrated site, which complements the CMO's sites in Biberach, Germany, and Vienna, Austria. The site is the work home of 300 employees. Announcement

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.